Aeterna Zentaris Inc
TSX:AEZS

Watchlist Manager
Aeterna Zentaris Inc Logo
Aeterna Zentaris Inc
TSX:AEZS
Watchlist
Price: 5.1 CAD -0.97% Market Closed
Market Cap: 18.9m CAD

Wall Street
Price Targets

AEZS Price Targets Summary
Aeterna Zentaris Inc

There are no price targets for AEZS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aeterna Zentaris Inc Competitors:
Price Targets
TNG
Transgene SA
62% Upside
2616
CStone Pharmaceuticals
138% Upside
LVTX
LAVA Therapeutics NV
20% Downside
688363
Bloomage Biotechnology Corp Ltd
9% Upside
87S
Roivant Sciences Ltd
15% Upside
MOLN
Molecular Partners AG
166% Upside
SCLP
Scancell Holdings PLC
212% Upside
CGON
CG Oncology Inc
87% Upside

Revenue
Forecast

Revenue Estimate
Aeterna Zentaris Inc

For the last 8 years the compound annual growth rate for Aeterna Zentaris Inc's revenue is 32%. The projected CAGR for the next 1 year is -2%.

32%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Aeterna Zentaris Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Aeterna Zentaris Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AEZS's stock price target?
Not Available

AEZS doesn't have any price targets made by Wall Street professionals.

What is Aeterna Zentaris Inc's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Aeterna Zentaris Inc's revenue is 32%. The projected CAGR for the next 1 year is -2%.

Back to Top